Latest available resultsQuarter ended June 30, 202610-Q · July 15, 2026
Filed with the SECElevance Health, Inc.
ELVHealthcare
Next reportOctober 19, 2026pre-market · Analyst forecast 4.699 $/share
Revenue
$50.47B
▲ +1.4% vs prior year% YoY
Net income
$1.46B
▼ -16.1% vs prior year% YoY
EPS
6.71$
▼ -13.1% vs prior year% YoY
Net margin
2.9%
▼ -0.6 percentage points vs prior year pp YoY
Revenue▲ +1.4 %
Margins (% of revenue)GrossOperatingNet
Net income▼ -16.1 %
EPS▼ -13.1 %
View financial tableQuarter ended June 30, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $50.47B | |
| Gross profit | $44.98B | 89.1 % |
| Operating income | $1.76B | 3.5 % |
| Net income | $1.46B | 2.9 % |
| R&D | — | never filed |
| EPS (diluted) | 6.71 $ | |
| Balance sheet | ||
| Assets | $126.44B | |
| Liabilities | $81.42B | |
| Equity | $45.02B | |
| Cash | $10.23B | |
| Capital | ||
| Shares outstanding | 216.87M | as of 2026-07-10 |
| Public float | — | |